Art

J-GLOBAL ID：202302242320716341   Reference number：23A3108140

Clinical Guidelines for Primary Sclerosing Cholangitis

胆膵疾患関連の診断基準と診療ガイドライン 原発性硬化性胆管炎診療ガイドライン

Author (2)： MIZUNO SUGURU (埼玉医大 消化器内科・肝臓内科) ,  ISAYAMA HIROYUKI (順天堂大 医 消化器内科)
Material： 胆と膵  (胆とすい)
Volume： 44  Issue： 特別号  Page： 1407-1412  Publication year： Nov. 01, 2023 
JST Material Number： Z0153B  ISSN： 0388-9408  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *clinical practice guideline ,...
Semi thesaurus term： *Primary sclerosing cholangitis ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=23A3108140&from=J-GLOBAL&jstjournalNo=Z0153B") }}

JST classification (1)： Digestive system diseases  (GH03000W)

Substance index (1)： Ursodeoxycholic Acid

Reference (17)：

• Isayama H, Tazuma S, Kokudo N, et al. : Clinical guidelines for primary sclerosing cholangitis 2017. J Gastroenterol 53 : 1006-1034, 2018.
• Nakazawa T, Notohara K, Tazuma S, et al. : The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol 52 : 838-844, 2017.
• Lindor KD, LaRusso NF : Primary sclerosing cholangitis. Schiffs disease of the liver, Schiff ER, 9th edition, 673-684, JB Lippincott, Philadelphia, 2003.
• Tanaka A, Tazuma S, Nakazawa T, et al. : No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan. J Hepatobiliary Pancreat Sci 24 : 217-225, 2017.
• Yoshida H, Shiokawa M, Kwada T, et al. : Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis. J Gastroenterol 58 : 778-789, 2023.

Terms in the title (4)： 膵疾患 ,  診断基準 ,  診療ガイドライン ,  原発性硬化性胆管炎